INGN Kevin Raymond Smith MERRILL buys $100K worth of shares
Mar 05, 2025, 5:31 AM
0.00%
What does INGN do
Inogen, based in Goleta, California, develops portable oxygen concentrators for chronic respiratory patients and went public on February 14, 2014. Their products include Inogen One systems, Inogen Connect, and Simeox airway clearance devices.
Kevin Raymond Smith MERRILL bought 11,709 shares of INGN on 3 March at $8.56 per share, worth a total of $100K. They now own 70,274 INGN shares, or a 20% holding increase.
📡️ Health Care
Insider Trades
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.